- Home
- Life Sciences
- Neurology Devices
Neurology Devices Market Research Report – Segmented By Region (North America, Europe, Asia-Pacific, Middle-East & Africa, Latin America) – Analysis on Size, Share, Trends, COVID-19 Impact, Competitive Analysis, Growth Opportunities and Key Insights from 2019 to 2030.
-
Published date -30th Jan 2024
-
Formats -PDF, CSV
-
Region -Global
Neurology Devices Market Analysis
1. What is the Market Size & CAGR of Neurology Devices market in 2021?
The global neurology devices market had a market size of USD 10.5 billion in 2021 with a Compound Annual Growth Rate (CAGR) of 5.2%.
2. COVID-19 Impact on the Neurology Devices Market
The COVID-19 pandemic had a significant impact on the neurology devices market, leading to disruptions in the supply chain, delays in product launches, and a temporary decline in market growth.
3. Neurology Devices Dynamics
The neurology devices market is driven by factors such as an increasing prevalence of neurological disorders, technological advancements in the healthcare sector, and a growing elderly population.
4. Segments and Related analysis
The neurology devices market is segmented based on product type, technology, and end-user. The key segments include neurostimulation devices, neurosurgical devices, and neurodiagnostic devices.
5. By Region Analysis
The neurology devices market is analyzed across regions such as North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. North America leads the market due to advanced healthcare infrastructure and a high prevalence of neurological disorders.
6. Key Market Players and Competitive Landscape
Key players in the neurology devices market include Medtronic, Abbott Laboratories, Boston Scientific Corporation, and Stryker Corporation. The market is highly competitive, with companies focusing on product development and strategic partnerships.
7. Recent happenings in the Neurology Devices Market
Recent developments in the neurology devices market include the launch of innovative neurostimulation devices, strategic collaborations between companies for research and development, and the adoption of telemedicine solutions for neurology consultations.
